可孚医疗
(301087)
| 流通市值：98.16亿 | | | 总市值：119.36亿 |
| 流通股本：1.94亿 | | | 总股本：2.36亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 3,190,990,989.37 | 2,071,847,991.36 | 1,012,368,240.57 | 3,387,499,253.24 |
| 营业总成本 | 2,852,162,092.66 | 1,846,039,389.15 | 885,037,584.77 | 3,038,805,623.01 |
| 其他经营收益 | | | | |
| 营业利润 | 365,952,481.71 | 244,414,064.19 | 128,666,168.48 | 429,044,340.65 |
| 利润总额 | 365,385,788.61 | 244,070,290.19 | 129,032,197.45 | 425,842,807.11 |
| 净利润 | 306,587,671.21 | 203,199,082.13 | 107,411,758.99 | 370,316,214.99 |
| 每股收益 | | | | |
| 其他综合收益 | -24,672,738.89 | -6,576,014.49 | -2,847,497.23 | -1,767,715.86 |
| 综合收益总额 | 281,914,932.32 | 196,623,067.64 | 104,564,261.76 | 368,548,499.13 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 4,753,959,875.29 | 4,637,822,544.71 | 4,163,988,017.84 | 3,835,321,664.48 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,842,370,179.26 | 2,819,629,769.84 | 2,749,398,987.44 | 2,793,593,565.55 |
| 资产总计 | 7,596,330,054.55 | 7,457,452,314.55 | 6,913,387,005.28 | 6,628,915,230.03 |
| 流动负债: | | | | |
| 流动负债合计 | 1,916,387,534.33 | 1,763,235,410.23 | 2,010,042,327.32 | 1,588,765,842.51 |
| 非流动负债: | | | | |
| 非流动负债合计 | 298,742,158.98 | 131,499,680.22 | 135,441,955.2 | 137,260,900.1 |
| 负债合计 | 2,215,129,693.31 | 1,894,735,090.45 | 2,145,484,282.52 | 1,726,026,742.61 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,347,027,752.59 | 5,526,720,823 | 4,731,839,687.12 | 4,866,857,736.11 |
| 股东权益合计 | 5,381,200,361.24 | 5,562,717,224.1 | 4,767,902,722.76 | 4,902,888,487.42 |
| 负债和股东权益合计 | 7,596,330,054.55 | 7,457,452,314.55 | 6,913,387,005.28 | 6,628,915,230.03 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 3,396,341,134.19 | 2,247,422,221.67 | 1,117,854,092.74 | 3,779,567,063.09 |
| 经营活动现金流出小计 | 3,132,273,126.46 | 1,985,010,905.98 | 1,015,293,959.85 | 3,083,841,246.38 |
| 经营活动产生的现金流量净额 | 264,068,007.73 | 262,411,315.69 | 102,560,132.89 | 695,725,816.71 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,164,890,889.11 | 809,252,497.45 | 151,986,902.43 | 2,288,300,077.52 |
| 投资活动现金流出小计 | 710,566,353.74 | 486,481,021.82 | 342,889,074.8 | 2,357,260,147.76 |
| 投资活动产生的现金流量净额 | 454,324,535.37 | 322,771,475.63 | -190,902,172.37 | -68,960,070.24 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 2,775,883,522.13 | 1,897,478,969.4 | 667,044,378.36 | 1,246,432,050.1 |
| 筹资活动现金流出小计 | 2,215,898,404.5 | 1,411,141,919.23 | 477,075,593.1 | 1,715,178,834.64 |
| 筹资活动产生的现金流量净额 | 559,985,117.63 | 486,337,050.17 | 189,968,785.26 | -468,746,784.54 |
| 汇率变动对现金及现金等价物的影响 | -23,849,499.41 | -15,314,840.11 | -3,225,998.04 | -3,429,799.77 |
| 现金及现金等价物净增加额 | 1,254,528,161.32 | 1,056,205,001.38 | 98,400,747.74 | 154,589,162.16 |
| 期末现金及现金等价物余额 | 2,549,103,462.02 | 2,350,780,302.08 | 1,392,976,048.44 | 1,294,575,300.7 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 1,056,205,001.38 | - | 154,589,162.16 |
最新报告期：2026-10-01| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中信建投 | 华冉,王在存,贺菊颖 | 1.97 | 2.48 | 3.05 | 2026-10-01 |
| 华创证券 | 郑辰,李婵娟,陈俊威 | 1.97 | 2.48 | 3.04 | 2026-09-29 |
| 中泰证券 | 祝嘉琦,谢木青 | 1.90 | 2.48 | 3.14 | 2026-09-08 |
| 华源证券 | 刘闯 | 1.97 | 2.47 | 3.02 | 2026-09-07 |
| 财信证券 | 龙靖宁 | 1.94 | 2.53 | 3.01 | 2026-08-31 |